Light chains are a ligand for megalin.
LIGHT CHAINS PRESENT in the urine of patients with multiple myeloma may be nephrotoxic. They appear to exert their effects by several independent mechanisms at different nephron sites (7, 13, 14) . Some nephrotoxic light chains can produce glomerular damage (amyloidosis and light chain deposition disease) either in combination with tubular pathology or alone (7, 13, 14) . Most of the proximal tubular damage results in an acute tubulopathy that histopathologically and clinically mimics acute tubular necrosis (13, 14) . A minority of patients have Fanconi syndrome (i.e., glucosuria, aminoaciduria, and phosphaturia) (13, 14) . Those patients, although also showing proximal tubular damage, also exhibit quite characteristic intracytoplasmic inclusions with a somewhat tubular/crystalline ultrastructural appearance (7, 13, 14) . A specific abnormality, an unusual hydrophobic residue, in the pathologic light chain in position 30 has been elucidated in patients with Fanconi syndrome (14) . It is important that acute tubular necrosis and the changes associated with Fanconi syndrome be properly differentiated for clinical and pathologic purposes (13) .
The chronic tubulointerstitial nephropathy that commonly accompanies multiple myeloma appears to be mediated by cytokines released by proximal tubular cells as a result of excessive light chain endocytosis (21) . This cytokine response appears to be mediated by MAP kinases (20) .
Light chains of diverse origin bind to renal tubular proteins. Mechanistic studies on renal tubular proteins demonstrate that light chains, independent of their source, consistently bind to cubilin in the proximal tubule (2) and to Tamm-Horsfall protein in the distal tubule (11) . Cubilin (gp280) is a giant glycoprotein receptor and peripheral membrane protein, abundant in the clefts between apical brush-border membrane microvilli (2, 16, 18) . Tamm-Horsfall protein is a glycoprotein secretory product of the ascending limb of the loop of Henle (11) .
Varied lines of evidence identify cubilin as an endocytic receptor for some immunoglobulin light chains (2) . First, light chains coelute during immunoaffinity purification of cubilin. Next, polyclonal antisera to cubilin, but not control sera, displace human light chain binding from rat renal brush-border membranes. Furthermore, anti-cubilin antiserum inhibit light chain uptake into cubilin-expressing visceral yolk sac endothelial cells. Last, cubilin bind multiple species of light chains in surface plasmon resonance (SPR) experiments. Binding shows dose-and time-dependent saturability with low-affinity, highcapacity equilibrium binding parameters with dissociation constants in micromolar range (1, 2) . These data demonstrate that cubilin plays a role in the endocytosis and trafficking of light chains in renal proximal tubule cells.
In addition to cubilin, however, several lines of evidence converge to suggest that another abundant proximal tubular glycoprotein receptor, megalin, also plays a role in light chain endocytosis (23, 24) . Classic binding kinetics studies using Scatchard analysis demonstrate that a number of ligands compete with light chains for brush-border membrane binding. These ligands include lysozyme, insulin, cytochrome c, myoglobin, and ␤ 2 -microglobulin (2, 4, 25) . Several of these ligands have been shown elsewhere to be ligands for megalin (4) . Additionally, in conscious rats, lysozyme, cytochrome c, and ␤ 2 -microglobulin compete with each other for uptake in the proximal tubules (3) . Taken together, these observations are consistent with the hypothesis that light chains bind to megalin as well as cubilin as the entry step to proximal tubular reabsorption. This study tests this hypothesis with both direct molecular and membrane techniques.
The molecular structures of both cubilin and megalin are consistent with multiple ligand binding domains of diverse affinities. Megalin is a 600-kDa glycoprotein receptor with a single transmembrane domain (15, 19) . It attracted intense interest after it was identified as the target of glomerulonephritic antisera, becoming known as "the Heymann antigen" (6, 15, 19) . Saito et al. (19) cloned the protein, finding a 5,044-residue protein with high homology to the low-density lipoprotein receptor family. The structure of cubilin, a 460-kDa protein, is characterized by 27 consecutive low-affinity ligand binding domains (2, 4), followed by 8 EGF repeats, but no transmembrane span (16) . Cubilin is a peripheral membrane protein anchored to the apical membrane of proximal tubule cells via attachment to megalin (16) .
METHODS AND MATERIALS
Animals, reagents, and antibodies. Male Sprague-Dawley rats (200 -250 g) were obtained from Sasco (Omaha, NE). All other reagents were from Sigma Chemicals (St. Louis, MO) unless otherwise stated.
Polyclonal antibodies against cubilin and megalin were raised in rabbits against proteins purified by immunoaffinity chromatography using previously reported monoclonal antibodies coupled to Sepharose 4B (2, 10, 17, 18) . These antibodies, used as whole serum preserved with azide, were monospecific by immunoblotting on whole brush border preparations and by immunoprecipitation of biosynthetically labeled yolk sac epithelial cells in culture (17, 18) . For a control antiserum, available antisera unrelated to cubilin or megalin but of the same species and isotype were surveyed by flow cytometry to find a serum with the same peak binding as the cubilin and megalin antisera. An anti-neurokinin (NK)-1/substance P receptor antiserum (a kind gift of Dr. Jacques Couraud, Gif-sur-Yvette, France) proved suitable (5) .
Light chains. To study a defined group of light chains, we selected light chains from patients with pure light chain proteinuria without albuminuria, consistent with a lack of glomerular disease. The patients did not have Fanconi syndrome clinically, but they did have tubulointerstitial nephropathy, consistent with distal cast formation. The light chains, purified as previously discussed (2, 3, 9) , were monomeric on Western blot and showed a single band of appropriate size on an SDS-PAGE gel. Two -light chains and two -light chains were studied.
Preparation of rat brush-border membrane vesicles, antibody binding studies, and ligand interference studies. Rat renal cortical brushborder membrane vesicles were isolated by magnesium precipitation techniques as described previously (1, 2, 10) . Human -light chains were labeled with FluorX, Cyanine-3 (Amersham, Boston, MA), or FITC (Sigma Chemical). Residual free dye was separated from light chain conjugated dye by dialysis into a suitable binding buffer using a Slidalyzer cassette (Pierre, Rockford, IL). Binding of light chains was investigated in presence of 1,000-to 2,000-fold dilutions of anti-cubilin or anti-megalin polyclonal antibodies recognizing the holoprotein (2, 10, 17, 18) . Binding of FluorX conjugated light chains to brush-border membrane vesicles, with and without antibody or ligand interference, was analyzed by flow cytometry using a FACStar Plus flow cytometer to collect data files of 2,000 observations per sample. FluorX was excited with the 488 nm line of an argon-ion laser, and fluorescence units were measured at 530 Ϯ 30 nm using a photo multiplier and log amplification of the arbitrarily zeroed signals (2, 10) . Data files were collected and analyzed using CellQuest software. For ligand interference studies, one light chain was fluorescent labeled and competition with other light chains assayed (2). Cyanine-3 conjugated metallothionein (MT) was prepared using the same method as for light chains.
Direct Biacore analysis of light chain/cubilin interaction using surface plasmon resonance technology. Surface plasmon resonance (SPR) experiments used a BIACORE 3000 instrument. Immobilizations were conducted at 25°C with a flow buffer at pH 7.4 containing 10 mM HEPES, 2 mM CaCl 2, 150 mM NaCl, and 0.005% NP-40. A Biacore CM5 dextran sensor chip was activated with N-hydroxysuccinimide and N-ethyl carbodiimide according to manufacturer protocols and cubilin (in 10 mM acetate, pH 4.8) was injected immediately afterward. Unreacted sites were blocked with 1 M ethanolamine (pH 8.5) (9, 16, 20, 22) . When a control (reference) surface was needed for quantitative measurements, an equal amount of casein (0.20 mg/ml in 10 mM acetate, pH 4.78) was immobilized in a parallel flow cell.
Surface plasmon resonance study of the dose-dependent binding of myeloma light chains to megalin. A solution of myeloma light chains (3.4 mg/ml in HBS) was serially diluted to prepare solutions ranging from 0.078 to 2.5 mg/ml. The blank contained only buffer. These solutions were repeatedly injected over the surface for 2.2 min (110 l at 50 l/min, 25°C). The association (injection) phase and a subsequent 5-min dissociation phase were monitored and corrected in real-time by subtracting the reference signal. After several minutes, the light chains had not entirely dissociated from the megalin, so a mildly acidic cocktail (pH 5.0) was injected to regenerate the surface. The raw binding data for the megalin cell were corrected by subtracting the casein reference signal to give the net response. Binding kinetics including association and dissociation constants were analyzed using Biacore analysis software.
Cell culture studies. Except as noted, experiments were conducted using immortalized yolk sac cells from the Brown Norway rat (BN-16) (17) . An apical brush border and a specialized endosomal pathway similar to the renal proximal tubule, including abundant expression of megalin and cubilin, characterize these cells. The cells were grown in DMEM (Gibco/Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum and 50 g/ml streptomycin or ciprofloxacin. Cells were passaged every 4 days with a split ratio of 10:1. Madin-Darby canine kidney cells were grown in a modified minimal essential medium as described in ATCC (Manassas, VA) protocols.
Light chain uptake by BN-16 cells analyzed by flow cytometry. Uptake experiments used FluorX-or Cy3-labeled light chains and were performed with confluent monolayers cultured in 96-well plates.
In preliminary experiments, we determined that light chain uptake was linear for at least 3 h and exhibited dose-dependent saturation. The concentration producing half-maximal uptake was ϳ5 M. Inhibition experiments were performed as follows. The confluent monolayers were washed with serum-free DMEM and allowed to equilibrate for 2 h at 37°C. The cells were then incubated with 5 M labeled light chains and any inhibitor for 1-2.5 h at 37°C. Incubations were performed in DMEM containing 0.1% ovalbumin to reduce nonspecific binding. The cells were washed several times with PBS, acidwashed to release membrane-bound proteins, released with trypsin, and washed several more times with PBS. In this state they could be analyzed immediately, without fixing, by flow cytometry analysis. The positive control was labeled light chains without added inhibitor; the negative control was unlabeled light chains. Inhibitor concentrations were generally 10 -100 times greater than the concentration of labeled light chains.
Statistics. Data are expressed as means Ϯ SE throughout the manuscript. Statistical analysis was performed by analysis of variance and Scheffé's post hoc comparison. The large data sets of 2,000 individual observations generated by flow cytometry analysis were analyzed for statistical significance by Kolgomorov-Smirnov summation statistics (27) . Flow cytometry measurements are log amplified to allow collection of the typically broad range of fluorescent values on a defined scale. Both the arithmetic and geometric means of the 2,000 individual cell measurements collected are calculated, along with the coefficient of variation (CV). If the distribution is tightly Gaussian, such that the CV is Ͻ0.5 the mean, then the arithmetic mean is shown, but if CV Ͼ 0.5 is the mean then the geometric correction is used. sera using flow cytometry techniques. In preliminary experiments we observed that anti-megalin and anti-cubilin antisera had classic binding curves to brush-border membrane vesicles and had the same peak titer. We surveyed a number of irrelevant sera of matching animal host and determined that an antibody to the NK-1 receptor had the same peak binding dilution as the anti-megalin and anti-cubilin sera, making it a suitable control. Human FITC-conjugated -1 light chains (FITC-LC) were used in this experiment. FITC-LC bound to rat renal brush-border membrane vesicles were displaced by polyclonal antibodies to either cubilin or megalin (Fig. 1) .
produced no effect. This suggests that the anti-cubilin and anti-megalin antiserum effects are highly specific. This flow cytometry data provide the first line of evidence that megalin, like cubilin, is a receptor for light chains, and, in fact, megalin appears to bind more light chains than cubilin.
Next we tested for competition between light chains and known megalin ligands for brush-border membrane vesicle binding (Fig. 2) . Light chain -1 was used for these experiments. Light chains fluorescently labeled with FITC bound significantly to brush-border membrane vesicles at 3 M concentration (control unlabeled 5 Ϯ 1 fluorescent units, mean Ϯ SE, labeled 374 Ϯ 42, n ϭ 4, P Ͻ 0.05; Fig. 2A ). Independent confirmation of the flow cytometry results was obtained through Biacore SPR measurements, which also showed that light chains bind to megalin (Fig. 3) . SPR analyses allow for direct real-time binding assays between an immobilized molecule and its soluble ligand (or its receptor, depending on the experimental design) (12) . In the case of light chains exposed to immobilized megalin, the responses for multiple injections of each light chain sample [light chains -1, -2, and -1 were highly reproducible over the concentration range 0.078 -2.5 mg/ml (Fig. 3A) ]. At all concentrations of light chain, the signal reached near equilibrium within 2 min. A fit of these data leads to an estimated dissociation constant of 6 ϫ 10 Ϫ5 M, a value similar to previously observed constants from our laboratory (1) (Fig. 3B) . Additionally, these data indicate a maximum binding of ϳ75 response units (RU), corresponding approximately to one light chain binding site per megalin. With Fig. 1 . Displacement of light chain binding to rat renal cortical brush-border membranes by anti-cubilin and megalin antisera using flow cytometry analysis. Anti-cubilin polyclonal antiserum inhibits FITC-light chain binding to rat renal brush-border membrane vesicles, but not nearly as much as megalin antiserum. In contrast, both normal rabbit serum and antisera to the neurokinin-1/ substance P receptor, which binds these membranes, has no effect on light chain binding. This suggests the cubilin and megalin antiserum effects are highly specific. Data are expressed as means Ϯ SE with statistical analysis by analysis of variance and Scheffé's post hoc comparison. a minor sigmoidal element in the early part of the binding curves we cannot exclude a more complex cooperativity model, but this would not change the conclusions regarding megalin/light chain interactions proposed from this analysis. As previously reported (2), the affinity of light chains for cubilin is in micromolar range and similar to the megalin/light chain interaction observed here.
Light chain uptake in cultured cells and inhibition by antibodies and ligands studied by flow cytometry. To determine the cellular uptake of fluorescently labeled light chains and inhibition by known megalin ligands we began with dose-and time-dependent uptake studies. Light chain -1 was used in these experiments. Incubation of BN-16 cells with 0 -80 M fluorescently labeled light chains for 3 h followed by flow cytometry analysis demonstrates that light chain uptake is saturable and that light chain concentrations of 4 -5 M produce half-maximal uptake (data not shown). Uptake of light chains by BN-16 cells was then demonstrated to be linearly time dependent at doses above and below the half-maximal binding concentration (data not shown).
Incubating BN-16 cells with anti-megalin antibodies before adding 10 M fluorescent light chain greatly reduced the uptake of light chain in a dose-dependent manner (Fig. 4) (unstained cells 8 Ϯ 3 arithmetic mean Ϯ SE, increases to 1,374 Ϯ 141; n ϭ 3, P Ͻ 0.05; with anti-megalin antisera at 1:100 dilution, 202 Ϯ 13; at 1:330 dilution, 515 Ϯ 12; at 1:1,000 dilution, 823 Ϯ 168; at 1:3,300 dilution, 1,106 Ϯ 36; n ϭ 3, P Ͻ 0.05 by Kolgomorov-Smirnov summation statistics on each run). At the same titer, anti-cubilin antiserum had a smaller, although significant, effect (at 1:100 dilution, 889 Ϯ 65; at 1:330 dilution, 1,312 Ϯ 69; at 1:1,000 dilution, 1,195 Ϯ 138; at 1:3,300 dilution, 1,366 Ϯ 74; n ϭ 3, P Ͻ 0.05 by Kolgomorov-Smirnov summation statistics on each run for dilutions 1:100, 1:330, and 1:1,000). Angiotensin II type 1 (AT 1 ) receptor antiserum, in contrast, had no effect (at 1:100 dilution, 1,255 Ϯ 46; at 1:330 dilution, 1,245 Ϯ 35; at 1:1,000 dilution, 1,245 Ϯ 101; at 1:3,300 dilution, 1,182 Ϯ 124; n ϭ 3). Antibodies against megalin and cubilin had an additive Fig. 3 . Dose-dependent binding of myeloma LC to megalin using surface plasmon resonance (SPR) analysis. Myeloma LC (3.4 mg/ ml) was serially diluted in HBS. These solutions were injected 3 times over the surface for 2.2 min. A: from bottom to top, the traces represent the corrected real-time responses obtained for concentrations of 0, 0.078, 0.156, 0.312, 0.625, 1.25, and 2.5 mg/ml. B: fit of the maximum (equilibrium) responses obtained within 2 min. Fig. 4 . Flow cytometry analysis of antibody inhibition of uptake of fluorescently labeled MT into BN-16 cells. Anti-cubilin antisera inhibited MT uptake into BN-16 cells in a concentration-dependent manner. Effect of anti-megalin antisera was far greater than anti-cubilin antisera; the 2 sera produced an additive effect. Anti-AT1-receptor antiserum, which also binds BN-16 cells, was used as a nonspecific binding control but had no effect on MT uptake. Data files of 2,000 observations per sample were collected, n ϭ 3, mean Ϯ SE shown, with statistical analysis by Kolgomorov-Smirnov summation statistics. effect (at 1:100 dilution, 68 Ϯ 1; at 1:330 dilution, 229 Ϯ 25; at 1:1,000 dilution, 594 Ϯ 132; at 1:3,300 dilution, 1,088 Ϯ 26; n ϭ 3, P Ͻ 0.05 by Kolgomorov-Smirnov summation statistics on each run against both anti-megalin and anti-cubilin alone). The effect of antibodies on light chain uptake was not observable unless ovalbumin was used to reduce nonspecific effects.
To determine if there is competition between light chains for BN-16 cell uptake, 3 M fluorescently labeled -1 light chain was added with 3, 30, or 300 M of the four light chains, -1, -2, -1, and -2, and fluorescent light chain uptake assayed by flow cytometry (Fig. 5) . The pattern was quite similar when fluorescent light chain was used at 9 M rather than 4 M (Fig. 6B) . There was significant uptake of 4 M light chain at 2 h (control 12 Ϯ 2 fluorescent units, mean Ϯ SE compared with light chain 598 Ϯ 
DISCUSSION
Previous studies from our laboratories provided evidence that nephrotoxic myeloma light chains bind cubilin (2) . Two -light chains and two -light chains bound cubilin in a dose-dependent, temperature-dependent, competitive manner during SPR analysis of isolated protein binding. Antiserum to cubilin abolished substantial amounts of the brush-border membrane binding of a nephrotoxic light chain. Cubilin and light chains coeluted from an anti-cubilin monoclonal affinity column. Hence we concluded that myeloma light chains bind cubilin (2) . In the kidney, cubilin is restricted in distribution to the proximal tubule, and, clinically, the proximal tubular damage of myeloma light chains results in either an acute tubulopathy that mimics acute tubular necrosis in the majority of cases, whereas a minority of patients have Fanconi syndrome (7, 13, 14) . It is unclear to what extent the interaction of cubilin with light chains mediates the clinical pathology of myeloma.
As light chains are the variable regions of an antibody they are structurally diverse, and the critical determinants of proximal and distal toxicity have yet to be definitively identified (2, 11, 26) . Excessive endocytosis and protein overloading in proximal tubular cells appear to result in release of inflammatory cytokines that may be responsible for chronic tubulointerstitial nephritis, which is common in multiple myeloma (11, 20) . These data suggest that light chains bind the tandem megalin-cubilin complex, and some light chains bind preferentially to megalin rather than cubilin. Classic binding kinetics studies using Scatchard analysis demonstrate that a number of the ligands, which compete with light chains for brush-border membrane binding, are known ligands for megalin (25) . This study provides direct surface plasmon resonance, membrane vesicles antibody displacement data, and BN-16 cell uptake data consistent with the finding that light chains are indeed a ligand for megalin. The affinity of the light chains studied for megalin is quite similar to the affinity of light chains for cubilin and to affinity constants derived from radiolabeled light chain binding to rat renal brush-border membranes previously observed in our laboratory (1) .
The new insight to pathogenesis deduced from the current studies is that even in patients without Fanconi syndrome, or glomerular injury, but with clinical tubulointerstitial nephritis, light chains bind megalin and are taken up by megalin-expressing cell epithelia. Hence it appears that megalin binding and uptake are not sufficient for Fanconi syndrome formation or glomerulopathy. Resistance to cathepsin B proteolysis and subsequent accumulation in proximal tubular endosomes has been associated with Fanconi Syndrome.
Messiaen et al. (14) reappraised the unifying concept that patients with Fanconi syndrome and Bence Jones proteinuria have a special form of plasma cell dyscrasia characterized by slow progression of the tumor and by prominent crystal formation in proximal tubule cells, in the absence of myeloma casts in the distal tubule (8) . Resistance of the variable portion of -light chains to proteolysis in Fanconi syndrome patients can explain the accumulation of the light chain in the endocytotic compartment of the proximal tubule cells, leading to impairment of proximal tubule functions.
This new understanding of the interactions of light chains with the renal proximal tubular scavenger pathway receptors, cubilin and megalin, demonstrates that megalin is the major mediator of proximal tubular light chain reabsorption: the renal cellular entry mechanism for light chains has now been defined. This new information may well prove important for the eventual development of clinical protective agents for the proximal tubular elements of the nephrotoxic damage caused by light chains in patients with myeloma.
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